Sascha Tuchman, MD, MHS | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Sascha Tuchman, MD, MHS

Sascha Tuchman, MD, MHS

Healthcare Professional
Director
UNC Multiple Myeloma and Amyloidosis Program
UNC Hospitals Adult Oncology Clinics
101 Manning Drive
North Carolina, Cancer Hospital
Second Floor
Chapel Hill, North Carolina, United States
Sascha Tuchman is Associate Professor and Director of the University of North Carolina Multiple Myeloma and Amyloidosis Program. He earned his medical degree from Georgetown University School of Medicine followed by internal medicine residency, chief residency, and hematology-medical oncology fellowship at Duke University.
 
Sascha Tuchman is an expert in managing patients with multiple myeloma, amyloidosis, and other plasma cell disorders. He has conducted NIH-supported lab research but now focuses on clinical research in treating multiple myeloma in patients who are at high risk for toxicity due to advanced age or other medical problems, developing novel drugs for treating all patients with multiple myeloma and optimizing management for amyloidosis. 
 
Dr. Tuchman focuses his clinical practice and research efforts on multiple myeloma and amyloidosis of all subtypes. He has conducted NIH-funded research, participated in clinical trials, and authored multiple publications in these disorders.
 
 
Representative Publications:
 
 
 
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close